Diagnostic and prognostic performance of circulating biomarkers in ovarian cancer
Year: 2026
Type: article
Abstract: Introduction: Ovarian cancer is a leading cause of gynaecological cancer mortality. Ca125, the most widely used serum biomarker, has limited sensitivity for early-stage and type I tumours, prompting evaluation of additional blood-based markers. This umbrella review assesses the diagnostic and prognostic performance of serum and blood biomarkers in ovarian cancer.
Source: Academia oncology.
Authors: Rui Wu, Georgia Zachou, Agnieszka Michael
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7141678750
